AC Immune is a small Swiss company that has been in existence since 2003, but just recently IPO-ed on NASDAQ. The company is developing novel therapeutic and diagnostic agents for treating, diagnosing and vaccinating various neurodegenerative diseases, including Alzheimer’s Disease.

*** L3 or above subscription required to read the rest of the article ... Login or Subscribe/Upgrade here